ANTIBIOTIC SCREEN FOR ISOPRENOID PATHWAY IN B.ANTHRACIS

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43AI053048-01
Agency Tracking Number: AI053048
Amount: $98,560.00
Phase: Phase I
Program: SBIR
Awards Year: 2002
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
ECHELON BIOSCIENCES, INC.
ECHELON BIOSCIENCES, INC., 420 CHIPETA WAY, STE 180, SALT LAKE CITY, UT, 84108
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 MARK BROWN
 (801) 298-0455
 MBROWN@ECHELON-INC.COM
Business Contact
  HEAT
Phone: (801) 588-0455
Email: GTHEATH@ECHELON-INC.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Isoprenoid compounds form a large ubiquitous class of natural products that fulfill a wide variety of essential cellular functions in al living organisms. In eukaryotes, isoprenoid compounds are synthesized by a mevalonate (MVA) dependent pathway. However, in many bacteria, these compounds are synthesized by an alternative, MVA-independent route whose first committed intermediate is 2-methylerythritol 4-phosphate (MEP). Both pathways converge at isopentenyl diphosphate (IPP) and subsequent steps are similar in all organisms. Since the N EP pathway is absent in mammals, it is considered an attractive target for the development of novel antibiotics. The pathogen, Bacillus anthracis belongs to the MEP pathway class of organisms. We will prepare a transgenic bacterial E. coli host cell whose genome contains disruptions in a first endogenous gene in the N4EP pathway and a second endogenous gene which is located downstream of the first gene in the M P pathway. A transgene from B. anthracis that functionally replaces the disrupted downstream gene will be cloned into the cell. The growth of the host cell in the presence of test agent is then compared to a control culture to determine the activity of the test agent. Where the test agent renders the bacterial host cell inviable on media containing a chemical supplement to relieve the DXP block and viable on the media containing NIVA indicates that the test agent has the potential to be an effective antibacterial against B. anthracis.

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government